The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator.#sunpharma #halolfacility #usfda #cnbctv18 # ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

For the US import alert to be lifted, Sun Pharma must conduct an independent, retrospective assessment of its cleaning effectiveness and cross-contamination hazards. The company was given 15 working ...

Sun Pharmaceutical Industries posted a 5.2 percent year-on-year (YoY) rise in net profit for the third quarter of Financial ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

Sun Pharmaceutical Industries, a leading Indian pharma giant with revenues of over Rs. 38,400 crore plus, has posted consolidated revenue growth of 14 per cent during the third quarter ended December ...

Investing.com -- Among the biggest deal dispatches this past week, Sun Pharmaceutical said it would take out Concert Pharma ... to receive payment upon final FDA premarket approval to market ...

U.S. health officials say a company is recalling its over-the-counter eye drops that have been linked to an outbreak of ...

Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, reported a better-than-expected 5.2% rise in ...

Pharma major Glenmark ... dated 26th October 2022 informing you about the US FDA placing the Baddi (India) facility under import alert 66-40. We now wish to inform you that due to medical ...